Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
2011

Cancer Risk in Type 2 Diabetes Patients

Sample size: 26742 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hense Hans-Werner, Kajüter Hiltraud, Wellmann Jürgen, Batzler Wolf U

Primary Institution: Institute of Epidemiology and Social Medicine; Westphalian Wilhelms University

Hypothesis

What are the cancer incidence rates among patients with type 2 diabetes?

Conclusion

The study found that type 2 diabetes patients have a higher risk of developing certain types of cancer, particularly liver and pancreas cancers.

Supporting Evidence

  • 759 first cancers were identified among male T2D patients.
  • 605 first cancers were identified among female T2D patients.
  • The risk of any incident cancer in T2D was raised with a SIR of 1.14.
  • Insulin therapy was related to a higher cancer risk with a HR of 1.25.
  • SIRs for liver cancer were 1.94 and for pancreas cancer were 1.45.

Takeaway

People with type 2 diabetes are more likely to get some cancers, especially liver and pancreas cancers.

Methodology

The study used record linkage between a diabetes management program and a cancer registry to identify cancer cases among type 2 diabetes patients.

Potential Biases

Potential biases include loss to follow-up and competing risks of mortality from other causes.

Limitations

The follow-up period was short, and there may be underreporting of cancer cases due to reporting lags.

Participant Demographics

Participants were aged 40 to 79, with a mix of 12,650 men and 14,092 women.

Statistical Information

P-Value

0.01

Confidence Interval

[1.10 - 1.21]

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1758-5996-3-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication